Health Canada drug approval process: a barrier to personalized care in multiple sclerosis.
Oh J, Bhan V, Traboulsee A, Morrow SA, Lee L, Levin M, Casserly C, Freedman MS, Giacomini PS, Émond F, Smyth P, Clift F, Selchen D.
Oh J, et al. Among authors: morrow sa.
Can J Neurol Sci. 2024 May 23:1-12. doi: 10.1017/cjn.2024.267. Online ahead of print.
Can J Neurol Sci. 2024.
PMID: 38777804
No abstract available.